yes I will be happy and for the record I don't expect the company to be able to grow that far beyond 10% per annum, however I'm invested in CSL because I think this can be sustained for many, many years. The organic growth for a lot of its therapies is is in the mid to high single digit range, throw in some operating leverage and well executed acquisitions and the future could be bright. Though, I'll believe the sucess of Vifor when I see it...
Ann: CSL Results Announcement, page-23
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.58 |
Change
-1.210(0.40%) |
Mkt cap ! $145.5B | |||
| Open | High | Low | Value | Volume |
| $300.74 | $300.99 | $298.81 | $240.1M | 820.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $300.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $300.59 | 836 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |